Equities researchers at Cantor Fitzgerald initiated coverage on shares of Omega Healthcare Investors (NYSE:OHI) in a report issued on Wednesday. The firm set an “overweight” rating and a $34.00 price target on the real estate investment trust’s stock. Cantor Fitzgerald’s price objective indicates a potential upside of 25.46% from the company’s previous close.

The analysts wrote, “Operator issues come with the business. OHI is more exposed to skilled nursing than many of its peers, but challenged operators are not uncommon. We like skilled nursing and OHI’s management has many years of experience in the industry. We believe that skilled nursing is well-positioned as a post-acute provider to capitalize on the growing role of value-based reimbursement, and we believe that OHI’s problems with three operators will be resolved in 2018 as their portfolios are restructured or transitioned.””

Several other analysts have also commented on the stock. Hilliard Lyons lowered shares of Omega Healthcare Investors to a “buy” rating in a research report on Wednesday, November 1st. Capital One Financial reaffirmed an “equal weight” rating on shares of Omega Healthcare Investors in a research report on Sunday, October 22nd. ValuEngine raised shares of Omega Healthcare Investors from a “hold” rating to a “buy” rating in a research report on Friday, December 15th. Vetr lowered shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $32.96 price objective on the stock. in a research report on Monday, October 30th. Finally, Zacks Investment Research lowered shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a research report on Thursday, September 28th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $32.14.

Omega Healthcare Investors (NYSE OHI) traded down $0.49 during trading on Wednesday, reaching $27.10. 3,550,090 shares of the company traded hands, compared to its average volume of 2,192,042. Omega Healthcare Investors has a 1-year low of $26.43 and a 1-year high of $35.14. The stock has a market capitalization of $5,350.00, a PE ratio of 8.36, a PEG ratio of 2.95 and a beta of 0.49. The company has a current ratio of 3.40, a quick ratio of 3.40 and a debt-to-equity ratio of 1.18.

In other Omega Healthcare Investors news, Director Craig R. Callen purchased 10,000 shares of the stock in a transaction dated Thursday, November 2nd. The shares were bought at an average price of $27.38 per share, with a total value of $273,800.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Bernard J. Korman purchased 100,000 shares of the stock in a transaction dated Tuesday, October 31st. The stock was acquired at an average cost of $28.24 per share, for a total transaction of $2,824,000.00. Following the transaction, the director now owns 903,895 shares of the company’s stock, valued at $25,525,994.80. The disclosure for this purchase can be found here. Insiders own 1.54% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of OHI. Principal Financial Group Inc. raised its position in shares of Omega Healthcare Investors by 137.5% in the second quarter. Principal Financial Group Inc. now owns 5,503,823 shares of the real estate investment trust’s stock valued at $181,736,000 after purchasing an additional 3,186,783 shares during the period. FMR LLC raised its position in shares of Omega Healthcare Investors by 71.9% in the second quarter. FMR LLC now owns 2,349,289 shares of the real estate investment trust’s stock valued at $77,573,000 after purchasing an additional 982,771 shares during the period. Vanguard Group Inc. raised its position in shares of Omega Healthcare Investors by 2.3% in the second quarter. Vanguard Group Inc. now owns 32,497,878 shares of the real estate investment trust’s stock valued at $1,073,080,000 after purchasing an additional 735,367 shares during the period. BlackRock Inc. raised its position in shares of Omega Healthcare Investors by 3.6% in the second quarter. BlackRock Inc. now owns 20,606,999 shares of the real estate investment trust’s stock valued at $680,443,000 after purchasing an additional 717,086 shares during the period. Finally, LSV Asset Management raised its position in shares of Omega Healthcare Investors by 28.5% in the second quarter. LSV Asset Management now owns 1,724,155 shares of the real estate investment trust’s stock valued at $56,931,000 after purchasing an additional 382,200 shares during the period. 67.95% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This article was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/12/20/omega-healthcare-investors-ohi-coverage-initiated-by-analysts-at-cantor-fitzgerald.html.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.